Geode Capital Management, LLC Aridis Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.81 - $1.18 $5,680 - $8,275	7,013 Added 5.16%	143,034 $168,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $2.47 $18,849 - $63,777	25,821 Added 23.43%	136,021 $126,000
Q2 2022 Aug 12, 2022	BUY	$0.91 - $1.7 $3,240 - $6,053	3,561 Added 3.34%	110,200 $121,000
Q1 2022 May 13, 2022	BUY	$1.33 - $2.59 $91,324 - $177,842	68,665 Added 180.82%	106,639 $187,000
Q4 2021 Feb 11, 2022	BUY	$2.0 - $3.65 $4,150 - $7,573	2,075 Added 5.78%	37,974 $88,000
Q3 2021 Nov 12, 2021	BUY	$3.55 - $7.49 $127,441 - $268,883	35,899 New	35,899 $132,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.